glp-1 agonist dopamine Anti-Obesity Rx and Alcohol and Substance Use Disorders Myricetin and Dopamine - the
Description
Non-alcohol substance use disorder after bariatric surgery in the prospective, controlled Swedish Obese Subjects study
Interestingly, agmatine, a metabolite produced by the gut bacterium Bacteroides vulgatus was shown to impair ovarian function by inhibiting GLP-1 secretion through activation of the farnesoid X receptor (FXR) (Yun et al., 2024)
New Indications : GLP-1 drugs are being tested for obesity-related conditions (NASH/non-alcoholic steatohepatitis, cardiovascular risk reduction, etc.)
A.BergmanA.StevensC.KoteyP.YiB.ZhaoP.et al (2006a)
See if microdosing aligns with your personal health objectives
